Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01232738 is registered in ClinicalTrials.gov with Yunxia Wang, MD as lead sponsor.

NCT NCT01232738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01232738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Controlled Screening Trial of Safety and Efficacy of Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Yunxia Wang, MD
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2013
Enrollment
36 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)